Overview

Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of tolperisone (a non-opioid) or placebo administered in subjects with pain due to acute back muscle spasm.
Phase:
Phase 3
Details
Lead Sponsor:
Neurana Pharmaceuticals, Inc.
Treatments:
Tolperisone